PAPER Lage L, Rodriguez-Perez AI, Labandeira-Garcia JL, Dominguez-Meijide A

Fasudil inhibits α-synuclein aggregation through ROCK-inhibition-mediated mechanisms.

Neurotherapeutics. 2025 Feb 5;:e00544. Epub 2025 Feb 5 PubMed.

PAPER Jeong SH, Lee PH

Drug Repositioning and Repurposing for Disease-Modifying Effects in Parkinson's Disease.

J Mov Disord. 2025 Feb 7; Epub 2025 Feb 7 PubMed.

PAPER Al-Kuraishy HM, Sulaiman GM, Mohammed HA, Al-Gareeb AI, Albuhadily AK, Ali AA, Abu-Alghayth MH

Beyond amyloid plaque, targeting α-synuclein in Alzheimer disease: The battle continues.

Ageing Res Rev. 2025 Feb 4;105:102684. Epub 2025 Feb 4 PubMed.

PAPER Zhu M, Peng Q, Li S, Zhang G, Zhang Z

Irisin promotes autophagy and attenuates NLRP3 inflammasome activation in Parkinson's disease.

Int Immunopharmacol. 2025 Feb 5;149:114201. Epub 2025 Feb 5 PubMed.

PAPER Takasaki T, Yamada R, Sugimoto Y, Sugiura R

Alpha-Synuclein Fails to Form Aggregates in Endocytosis-Defective Fission Yeast Strains, ∆ myo1 and ∆ end4.

MicroPubl Biol. 2025;2025 Epub 2025 Jan 21 PubMed.

PAPER Yadav VK, Dhanasekaran S, Choudhary N, Nathiya D, Thakur V, Gupta R, Pramanik S, Kumar P, Gupta N, Patel A

Recent advances in nanotechnology for Parkinson's disease: diagnosis, treatment, and future perspectives.

Front Med (Lausanne). 2025;12:1535682. Epub 2025 Jan 22 PubMed.

PAPER Watanabe H, Shima S, Kawabata K, Mizutani Y, Ueda A, Ito M

Brain network and energy imbalance in Parkinson's disease: linking ATP reduction and α-synuclein pathology.

Front Mol Neurosci. 2024;17:1507033. Epub 2025 Jan 22 PubMed.

PAPER Guan T, Shang L, Yang P, Tan Z, Liu Y, Dong C, Li X, Hu Z, Su H, Zhang Y

Joint ensemble learning-based risk prediction of Alzheimer's disease among mild cognitive impairment patients.

J Prev Alzheimers Dis. 2025 Feb 5;:100083. Epub 2025 Feb 5 PubMed.

PAPER Song D, Gui F, Li G, Zhuang S, Sun J, Tan X, Hong C, Huang J

Neuritin improves cognitive impairments in APP/PS1 Alzheimer's disease mice model by mitigating neuronal ferroptosis via PI3K/Akt activation.

Int J Biol Macromol. 2025 Feb 4;303:140662. Epub 2025 Feb 4 PubMed.

PAPER Ryu SY, Lee C, Ho SH, Hong YJ, Jeong JH, Park KH, Wang MJ, Choi SH, Kim S, Yang DW

Longitudinal analysis of objective and self-reported cognitive functions in individuals with subjective cognitive decline.

Dement Geriatr Cogn Disord. 2025 Feb 6;:1-17. Epub 2025 Feb 6 PubMed.

PAPER Salamone EM, Carpi M, Noce G, Percio CD, Lopez S, Lizio R, Jakhar D, Eldellaa A, Isaza VH, Bölükbaş B, Soricelli A, Salvatore M, Güntekin B, Yener G, Massa F, Arnaldi D, Famà F, Pardini M, Ferri R, Salerni M, Lanuzza B, Stocchi F, Vacca L, Coletti C, Marizzoni M, Taylor JP, Hanoğlu L, Yılmaz NH, Kıyı İ, Kula H, Frisoni GB, Cuoco S, Barone P, D'Anselmo A, Bonanni L, Biundo R, D'Antonio F, Bruno G, Giubilei F, Antonini A, Babiloni C

Abnormal electroencephalographic rhythms from quiet wakefulness to light sleep in Alzheimer's disease patients with mild cognitive impairment.

Clin Neurophysiol. 2025 Jan 31;171:164-181. Epub 2025 Jan 31 PubMed.

PAPER Kowa H, Kumagai R, Oki Y, Imamura M, Suzuki Y

Tablet-based self assessment memory scale-revised (SAMS-R) evaluates memory functions for older adults.

Front Aging Neurosci. 2024;16:1512947. Epub 2025 Jan 22 PubMed.

PAPER Noh MY, Kwon MS, Oh KW, Nahm M, Park J, Jin HK, Bae JS, Son B, Kim SH

miRNA-214 to predict progression and survival in ALS.

J Neurol Neurosurg Psychiatry. 2025 Feb 6; Epub 2025 Feb 6 PubMed.

PAPER Modiri A, Abdolmaleki Z, Paryani MR

The effect of rosuvastatin coated by nano-chitosan on developing hippocampus: association with hippocampal neurogenesis and memory in an Alzheimer's induced model of rats.

Anat Cell Biol. 2025 Feb 7; Epub 2025 Feb 7 PubMed.

PAPER Cai M, Zhang X, Gao X, Huo Q, Sun Y, Dai X

Chitooligosaccharide ameliorates cognitive deficits and neuroinflammation in APP/PS1 mice associated with the regulation of Nrf2/NF-κB axis.

Int J Biol Macromol. 2025 Feb 4;:140683. Epub 2025 Feb 4 PubMed.